Bradenton, Florida Clinical Trials

A listing of Bradenton, Florida clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 204 clinical trials
featured
C2541013 MIRNA NASH  

The study aims to evaluate two, orally administered, investigational agents - PF-06865571 (DGAT2 inhibitor) and the coadministration of PF-06865571 with PF-05221304 (ACC inhibitor). This study is specifically designed to evaluate the effect of a range of doses of DGAT2i alone, and DGAT2i + ACCi, on resolution of NASH or improvement …

Florida Research Institute
 (2.6 away)
  • 261 views
  • 10 Jun, 2021
  • +58 other locations
featured
Cognitive Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Cognitive Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

memory impairment
memantine
acetylcholinesterase inhibitor
demented
acetylcholinesterase
Bradenton Research Center
 (8.8 away) Contact site
  • 850 views
  • 23 Nov, 2020
  • +2 other locations
featured
A Randomized Phase 3 Study of Sitravatinib in Combination with Nivolumab Versus Docetaxel in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer with Disease Progression On or After Platinum-Based Chemotherapy and Checkpoint Inhibitor Therapy (SAPPHIRE)

This is an open-label, randomized (1:1), multicenter, Phase 3 clinical trial evaluating the safety and efficacy of nivolumab in combination with investigational agent sitravatinib compared to docetaxel in patients with advanced non-squamous NSCLC who have previously experienced radiographic disease progression on or after treatment with platinum-based chemotherapy in combination with …

advanced lung cancer
squamous non-small cell lung cancer
non-squamous non-small cell lung cancer
docetaxel
lung cancer
SCRI - Florida Cancer Specialists - North Region Research Office
 (5.4 away) Contact site
  • 199 views
  • 24 May, 2021
  • +174 other locations
featured
A Phase III, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab in Autoinjectors, to Demonstrate Efficacy at 24 Weeks and Long Term Safety and Efficacy up to 3.5 Years in Subjects With Active Psoriatic Arthritis

A Phase III, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab in Autoinjectors, to Demonstrate Efficacy at 24 Weeks and Long Term Safety and Efficacy up to 3.5 Years in Subjects With Active Psoriatic Arthritis

Sarasota Arthritis Research Center
 (7.1 away) Contact site
  • 2362 views
  • 23 Nov, 2020
  • +17 other locations
featured
VIVID-1, a clinical research study for adults 18–80 with moderately to severely active Crohn’s disease.

A phase 3 research study of an injectable investigational medicine for adults ages 18 to 80 with moderate to severe Crohn’s disease. Note that study participants may receive the investigational medication, a currently approved Crohn’s medication, or placebo. The study comprises four periods: screening, treatment period 1, treatment period 2, …

gastrointestinal diseases
gastrointestinal disorder
crohn's disease
inflammatory bowel disease
VIVID-1 Study Center
 (6.0 away) Contact site
  • 66 views
  • 09 Jun, 2021
  • +74 other locations
A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease

This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determining the superiority of lecanemab compared with placebo on the change from baseline in the Clinical Dementia Rating-Sum of Boxes (CDR-SB) at 18 months of treatment in the Core Study. This …

Bradenton Research Center, Inc.
 (9.2 away) Contact site
  • 0 views
  • 29 Apr, 2021
  • +101 other locations
Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)

Semaglutide is a medicine studied in patients with NASH. Semaglutide is a well-known medicine, which is already used by doctors to treat type 2 diabetes in many countries. Participants will either get semaglutide or a dummy medicine - which treatment participants get is decided by chance. Participants will need to …

Novo Nordisk Investigational Site
 (7.1 away) Contact site
  • 0 views
  • 28 May, 2021
  • +218 other locations
Alinity m HR HPV Specimen Collection Study From Women Undergoing Routine Cervical Cancer Screening

A prospective multicenter interventional study will be conducted to enroll women undergoing routine cervical cancer screening to collect cervical liquid-based cytology (LBC) specimen(s). All subjects will have one cervical specimen collected. For a subset of approximately 1,650 randomly selected subjects, an additional cervical specimen will be collected. Cytology and HR …

Physician Care Clinical Research LLC
 (7.4 away) Contact site
  • 0 views
  • 20 May, 2021
  • +43 other locations
RESPONSE: Response to Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Control to or an Intolerance to Ursodeoxycholic Acid (UDCA)

To evaluate the treatment effect of seladelpar on composite biochemical improvement in cholestasis markers based on ALP and total bilirubin and to evaluate the safety of seladelpar over 12 months of treatment compared to placebo

Florida Research Institute
 (6.5 away) Contact site
  • 0 views
  • 09 Jun, 2021
  • +22 other locations
The Prevent Severe COVID-19 (PRESECO) Study

Double-blinded, placebo control, randomized, phase-3 clinical trial to evaluate clinical efficacy of Favipiravir in patients with mild to moderate symptoms related to COVID-19 infection

Synergy Healthcare
 (7.0 away) Contact site
  • 0 views
  • 01 Apr, 2021
  • +23 other locations